At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Stress and Inflammation in the Pathophysiology of Late Life Depression
In Brief
A Phase 4 clinical trial evaluating Escitalopram + Celecoxib and Escitalopram + Placebo for Depression and Inflammation. Completed, enrolled 119 participants across 1 site.
Detailed Summary
Over 18% of Americans aged 65 years and older have depression. Recent evidence suggests that there is a link between depression and inflammatory disease. This study investigates the relationship between inflammation in the brain and depression. Comparing biological and psychological differences in depressed and non-depressed people allows researchers to find better ways to treat and prevent depression. All participants will have: neuropsychological tests, an EKG, a spinal tap, a blood draw, and, if depressed, given either an antidepressant coupled with an anti-inflammatory medication or an anti-depressant coupled with a placebo for six weeks. The investigators are trying to correlate brain function with depression levels and biomarkers from the blood and spinal fluid.
Study Details
Timeline
Interventions
Participants will receive celecoxib in addition to escitalopram
Participants will receive a placebo in addition to escitalopram.